# A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity

> **NCT06737536** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 100 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** NNC0662-0419
- **OTHER:** Placebo (NNC0662-0419)

## Key facts

- **NCT ID:** NCT06737536
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-18
- **Primary completion:** 2025-07-26
- **Final completion:** 2025-07-26
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06737536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06737536, "A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06737536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*